<i>Glp1r-Lepr</i> coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist

Glucagon-like peptide-1 (GLP-1) and leptin signal recent feeding and long-term energy stores, respectively, and play complementary roles in the modulation of energy balance. Previous work using single-cell techniques in mice revealed the existence of a population of leptin receptor (<i>Lepr</i>)-containing dorsomedial hypothalamus (DMH) neurons marked by the expression of GLP-1 receptor (<i>Glp1r</i>; LepR<sup>Glp1r</sup> neurons) that play important roles in the control of feeding and body weight by leptin. Here, we demonstrate the existence of a population of LepR<sup>Glp1r</sup> neurons in the DMHs of nonhuman primates (NHPs), suggesting the potential translational relevance of these neurons. Consequently, we developed a GLP-1R/LepR dual agonist and demonstrated the physiological activity of both components in vivo using leptin-deficient and <i>Lepr-</i>deficient murine models. We further found roles for LepR<sup>Glp1r</sup> neurons in mediating the dual agonist's efficacy on food intake and body weight loss. Ablating <i>Lepr</i> in <i>Glp1r</i>-expressing neurons (Lepr<sup>Glp1r</sup>KO mice) abrogated the suppression of food intake by the dual agonist. Furthermore, reactivation of <i>Glp1r</i> expression in <i>Lepr</i> neurons on an otherwise <i>Glp1r</i>-null background (Glp1r<sup>Lepr</sup>Re mice) was sufficient to permit the suppression of food intake and body weight by the dual agonist. Hence, LepR<sup>Glp1r</sup> neurons represent targets for a GLP-1R/LepR dual agonist that potently reduces food intake and body weight.

Authors

Institutions

Publication Details

Journal
Science Translational Medicine
Published
2024-12-04
DOI
https://doi.org/10.1126/scitranslmed.adk4908
Citations
21
Primary Topic
Regulation of Appetite and Obesity
Type
article
Field-Weighted Citation Impact
5.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist

Sofia Lundh, Carsten E. Stidsen, I. Jack Magrisso, Wouter F. J. Hogendorf et al.
21 citations
Science Translational Medicine
Regulation of Appetite and Obesity
5.75
article

Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist

Sofia Lundh, Carsten E. Stidsen, I. Jack Magrisso, Wouter F. J. Hogendorf, Martin Grosvenor Myers, Stace Kernodle, Joseph Polex-Wolf, Christian W. Tornøe, Randy J. Seeley, S. Sherona Bau, Kristine Deibler, Abigail J. Tomlinson, Kilian W. Conde‐Frieboes, Charles Pyke, Lotte Bjerre Knudsen, Tine Glendorf, Dong Tiantang
article en
21 citations

Abstract

Glucagon-like peptide-1 (GLP-1) and leptin signal recent feeding and long-term energy stores, respectively, and play complementary roles in the modulation of energy balance. Previous work using single-cell techniques in mice revealed the existence of a population of leptin receptor (<i>Lepr</i>)-containing dorsomedial hypothalamus (DMH) neurons marked by the expression of GLP-1 receptor (<i>Glp1r</i>; LepR<sup>Glp1r</sup> neurons) that play important roles in the control of feeding and body weight by leptin. Here, we demonstrate the existence of a population of LepR<sup>Glp1r</sup> neurons in the DMHs of nonhuman primates (NHPs), suggesting the potential translational relevance of these neurons. Consequently, we developed a GLP-1R/LepR dual agonist and demonstrated the physiological activity of both components in vivo using leptin-deficient and <i>Lepr-</i>deficient murine models. We further found roles for LepR<sup>Glp1r</sup> neurons in mediating the dual agonist's efficacy on food intake and body weight loss. Ablating <i>Lepr</i> in <i>Glp1r</i>-expressing neurons (Lepr<sup>Glp1r</sup>KO mice) abrogated the suppression of food intake by the dual agonist. Furthermore, reactivation of <i>Glp1r</i> expression in <i>Lepr</i> neurons on an otherwise <i>Glp1r</i>-null background (Glp1r<sup>Lepr</sup>Re mice) was sufficient to permit the suppression of food intake and body weight by the dual agonist. Hence, LepR<sup>Glp1r</sup> neurons represent targets for a GLP-1R/LepR dual agonist that potently reduces food intake and body weight.

Science Translational MedicineVol. 16(776)
Novo Nordisk (Denmark) (DK), University of Michigan (US), Novo Nordisk (United States) (US), Novo Nordisk (Switzerland) (CH)
Eli Lilly and Company, Novo Nordisk, National Institutes of Health
Openalex Percentile: Top 3%
Regulation of Appetite and Obesity
5.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.